Santen Pharmaceutical Co. Ltd (SZD:F) Annual Income Statement ()
SZD:F Quarterly Financials ()
Frequently Asked Questions About Santen Pharmaceutical Co. Ltd (SZD:F) Stock
Santen Pharmaceutical Co. Ltd's (SZD:F) last reported annual revenue was EUR 279.04 Billion.
Santen Pharmaceutical Co. Ltd's (SZD:F) annual revenue growth rate based on the revenue reported in the past 5 years is : 4.40%
Santen Pharmaceutical Co. Ltd's(SZD:F) is not profitable as of its last reported annual financials.
The net profit margin for Santen Pharmaceutical Co. Ltd's(SZD:F) from its laster reported year is -5.36%
The return on equity (ROE) for Santen Pharmaceutical Co. Ltd's(SZD:F) from its last reported annual financials is : 9.26%
The return on assets (ROA) for Santen Pharmaceutical Co. Ltd's(SZD:F) from its last reported annual financials is : 12.03%
The return on invested capital (ROIC) for Santen Pharmaceutical Co. Ltd's(SZD:F) from its last reported annual financials is : -0.98%
The Debt to Equity ratio for Santen Pharmaceutical Co. Ltd's(SZD:F) from its last reported annual financials is : 0.00%
The dividend yield for Santen Pharmaceutical Co. Ltd's(SZD:F) from its laster reported year is 2.39%
Santen Pharmaceutical Co. Ltd's(SZD:F) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SZD:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
